State Street’s bioAffinity Technologies BIAF Stock Holding History

State Street’s Portfolio BIAF Stock Details BIAF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$55.1K	Buy	+14,386	New	+$23.2K	﹤0.01%	4116
2025 Q3	–	Sell	-587	Closed	-$5.05K	–	4293
2025 Q2	$5.05K	Hold	587	–	–	﹤0.01%	4253
2025 Q1	$4.58K	Hold	587	–	–	﹤0.01%	4271
2024 Q4	$16.4K	Hold	587	–	–	﹤0.01%	4249
2024 Q3	$36.6K	Hold	587	–	–	﹤0.01%	4146
2024 Q2	$38K	Hold	587	–	–	﹤0.01%	4192
2024 Q1	$35.6K	Hold	587	–	–	﹤0.01%	4212
2023 Q4	$26.2K	Hold	587	–	–	﹤0.01%	4313
2023 Q3	$21.5K	Hold	587	–	–	﹤0.01%	4434
2023 Q2	$32.2K	Hold	587	–	–	﹤0.01%	4524
2023 Q1	$33.3K	Buy	+587	New	+$34K	﹤0.01%	4605

Other funds holding BIAF

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JSSH

J. Safra Sarasin Holding $5.87B AUM 24.95% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

AAS

Ameritas Advisory Services Lincoln, Nebraska $2.58B AUM 18.84% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

State Street's BIAF Position: Q1 2026 in Review

State Street opened a new position in bioAffinity Technologies (BIAF) in Q1 2026: 14,386 shares worth $55.1K. The stake represents ﹤0.01% of the portfolio and ranks #4116 among its holdings. This is a return to the name: State Street previously reported a position in BIAF as recently as Q2 2025.

State Street first reported a position in BIAF in Q1 2023 and has held it in 11 quarters since. 14 funds tracked by Wall St. Rank hold BIAF as of Q1 2026.

State Street held 14,386 shares of bioAffinity Technologies worth $55.1K as of Q1 2026.
bioAffinity Technologies was a new State Street position in Q1 2026.
bioAffinity Technologies made up ﹤0.01% of State Street's portfolio in Q1 2026, its #4116 holding.
State Street first reported a position in bioAffinity Technologies in Q1 2023 and has held it in 11 quarters since.
14 funds tracked by Wall St. Rank held bioAffinity Technologies as of Q1 2026.

Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.